status

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from…

7 months ago

Hexaware Achieves AWS Premier Tier Status in the Amazon Web Services Partner Network

MUMBAI, India and ISELIN, N.J.  , Sept. 2, 2025 /PRNewswire/ -- Hexaware Technologies, a global provider of IT solutions and services,…

7 months ago

Sirona Biochem Update to Shareholders on Financial Status and Operations

August 01, 2025 16:30 ET  | Source: Sirona Biochem Corp. VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona…

8 months ago

DP WORLD DELIVERS SAILGP FLEET TO PORT TARGETING NET-ZERO STATUS

DP World, SailGP's Global Smart Logistics Partner, delivers racing fleet into Port of Southampton, ahead of the Emirates Great Britain…

8 months ago

WIKATI Accredited with ICEF Agency Status

HYDERABAD, India, July 8, 2025 /PRNewswire/ -- WIKATI Education Services LLC has been awarded the ICEF Agency Status (IAS), a…

8 months ago